Tridesfluoro benzene diamide Sitagliptin impurity
| CAS No. | : NA |
| Mol F. | : C26H26F6N6O2 |
| Mol W. | : 568.51 |
| Cat No. | : SA10429 |
- Description
- Quick Enquiry / RFQ
Description
| Product Name | Tridesfluoro benzene diamide Sitagliptin impurity |
| Synonyms | (R)-3-amino-N-((R)-4-oxo-1-phenyl-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide |
| Related API | Sitagliptin |
| Category | Impurities |
Tridesfluoro benzene diamide Sitagliptin impurity product with CAS: NA is also known as (R)-3-amino-N-((R)-4-oxo-1-phenyl-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide. This product can be used as a working standard or secondary reference standard. Additional internal validation as per respective FDA regulations/guidelines may require. Tridesfluoro benzene diamide Sitagliptin impurity is generally used for Quality Control (QC), Quality Assurance (QA) during commercial production of Sitagliptin and its related formulations. Moreover, (R)-3-amino-N-((R)-4-oxo-1-phenyl-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation.
If you need different pack size / quantity, please contact us or email us at [email protected]
